Raily Aesthetic Medicine International Holdings Limited (HK:2135) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Raily Aesthetic Medicine International Holdings Limited announced the disposal of its subsidiary, following the non-fulfillment of a profit guarantee by Jiumei Xinhe, which reported a net profit significantly below expectations for the year ending March 2024. The disposal, classified as a discloseable transaction, does not require shareholders’ approval under Hong Kong’s Listing Rules. This move reflects the company’s efforts to streamline operations and focus on more profitable ventures.
For further insights into HK:2135 stock, check out TipRanks’ Stock Analysis page.